Antipodes Partners’s UBS Group UBS Stock Holding History
Bought
Maintained
Sold
Other funds holding UBS
VCM
CCI
Antipodes Partners's UBS Position: Q1 2026 in Review
Antipodes Partners reduced its UBS Group (UBS) stake by 34% in Q1 2026, selling an estimated $13M and leaving 587,054 shares worth $22.5M. The position accounts for 0.43% of the portfolio, ranked #50.
Antipodes Partners first reported a position in UBS in Q3 2024 and has held it in 7 quarters since. The position peaked at $82M in Q2 2025. 681 funds tracked by Wall St. Rank hold UBS as of Q1 2026.
- Antipodes Partners held 587,054 shares of UBS Group worth $22.5M as of Q1 2026.
- Antipodes Partners sold 303,378 UBS Group shares in Q1 2026, an estimated $13M.
- UBS Group made up 0.43% of Antipodes Partners's portfolio in Q1 2026, its #50 holding.
- Antipodes Partners first reported a position in UBS Group in Q3 2024 and has held it in 7 quarters since.
- Antipodes Partners's UBS Group position peaked at $82M in Q2 2025.
- 681 funds tracked by Wall St. Rank held UBS Group as of Q1 2026.
Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.